Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition

This 250+ page report provides a comprehensive overview of the pediatric drug delivery market and includes relevant market data, key players, pharmaceutical product information, drug delivery technology profiles, and partnering opportunities. This industry report was written to stimulate development and marketing partnerships in the pharmaceutical industry that will ultimately result in products that better serve …

KOL Insight: Prostate Cancer: Competition intensifies in race to the top

The Prostate Cancer market has seen a number of progressive changes in recent years. The launches of Johnson & Johnson's Zytiga (abiraterone acetate) and Medivation/Astellas's Xtandi (enzalutamide) has reinvigorated the post-chemo treatment segment, while launch of the first cancer vaccine Provenge (sipuleucel-T; Dendreon) and Zytiga's expanded approval had finally given new options in the pre-chemo …

OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) – Opportunity Analysis and Forecasts to 2024

OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) – Opportunity Analysis and Forecasts to 2024 Summary Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) pneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold, and later …